Alfred Peter Born Selected Research

trans-sodium crocetinate (crocetin)

12/2019

Everolimus as adjunctive treatment in tuberous sclerosis complex-associated epilepsy in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfred Peter Born Research Topics

Disease

2	Seizures (Absence Seizure) 01/2022 - 12/2019
2	Epilepsy (Aura) 01/2022 - 12/2019
2	Stroke (Strokes) 01/2021 - 11/2013
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 08/2020 - 01/2019
2	Rheumatic Diseases (Rheumatism) 01/2019 - 08/2015
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 08/2015
1	Chronic Disease (Chronic Diseases) 04/2022
1	Juvenile Myoclonic Epilepsy 01/2022
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022
1	Idiopathic Generalized Epilepsy 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 12/2019
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 07/2019
1	Cerebral Palsy (Spastic Diplegia) 05/2019
1	Tardive Dyskinesia 05/2019
1	Dystonia (Limb Dystonia) 05/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Central Nervous System Infections (Central Nervous System Infection) 01/2019
1	Multiple Sclerosis 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 08/2018
1	Leukemia 09/2017
1	Succinate-Coa Ligase Deficiency 03/2016
1	Methylmalonic acidemia 03/2016
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 11/2015
1	Cytochrome-c Oxidase Deficiency 03/2015
1	Obesity 03/2015
1	Muscular Diseases (Myopathy) 02/2015
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2015
1	Muscle Hypotonia (Hypotonia) 12/2014
1	X-Linked Mental Retardation (Mental Retardation, X Linked) 12/2014
1	Thrombosis (Thrombus) 11/2013
1	Muscle Weakness 02/2010
1	Griscelli syndrome type 2 02/2010
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2010
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2010

Drug/Important Bio-Agent (IBA)

2	nusinersenIBA 08/2020 - 01/2019
2	AntibodiesIBA 07/2019 - 02/2015
2	GlucocorticoidsIBA 01/2019 - 08/2015
2	Oligoclonal BandsIBA 01/2019 - 08/2018
1	Antidepressive Agents (Antidepressants)IBA 04/2022
1	Ethosuximide (Zarontin)FDA LinkGeneric 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 08/2020
1	Everolimus FDA Link 12/2019
1	trans-sodium crocetinate (crocetin)IBA 12/2019
1	Botulinum Toxins (Botulinum Toxin)IBA 05/2019
1	ChitinasesIBA 08/2018
1	Methotrexate (Mexate)FDA LinkGeneric 09/2017
1	Mitochondrial DNA (mtDNA)IBA 03/2016
1	EnzymesIBA 03/2016
1	Succinate-CoA Ligases (Succinyl Coenzyme A Synthetases)IBA 03/2016
1	Immunoglobulins (Immunoglobulin)IBA 11/2015
1	SteroidsIBA 11/2015
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 03/2015
1	Cholinergic ReceptorsIBA 02/2015
1	Met Transfer RNAIBA 01/2015
1	Thyroid HormonesIBA 12/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2010

Therapy/Procedure

1	Therapeutics 01/2021
1	Ketogenic Diet 12/2019
1	Vagus Nerve Stimulation 12/2019
1	Deep Brain Stimulation 05/2019
1	Stents 11/2013
1	Thrombectomy 11/2013
1	Cell Transplantation 02/2010